Company Filing History:
Years Active: 2009-2018
Title: Naoko Watanabe: Innovator in Pharmaceutical Chemistry
Introduction
Naoko Watanabe is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to drug discovery.
Latest Patents
Watanabe holds 2 patents, with his latest inventions focusing on important pharmacological compounds. One of his notable patents is a PDE4 inhibitor, which includes a compound represented by formula (1a) or a pharmacologically acceptable salt thereof. This compound serves as a phosphodiesterase (PDE) inhibitor, with R to R in the formula representing alkyl groups or similar structures. Another significant invention involves the PF1270A, B, and C substances, which are novel compounds that exhibit high affinity for histamine H receptors. These substances are expected to serve as valuable ligands in the development of new medicaments.
Career Highlights
Throughout his career, Watanabe has worked with prominent companies in the pharmaceutical industry, including Meiji Seika Pharma Co., Ltd. and Meiji Seika Kaisha, Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Watanabe has collaborated with several talented individuals in his field, including Chika Kikuchi and Yuji Tabata. These collaborations have fostered a creative environment that has led to the advancement of pharmaceutical research and development.
Conclusion
Naoko Watanabe's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the industry. His work continues to pave the way for new therapeutic options and advancements in medicine.